Clinical outcomes following discontinuation of metformin in patients with type 2 diabetes and advanced chronic kidney disease in Hong Kong: a territory-wide, retrospective cohort and target trial emulation study-Reference-Cited by-同舟云学术

Clinical outcomes following discontinuation of metformin in patients with type 2 diabetes and advanced chronic kidney disease in Hong Kong: a territory-wide, retrospective cohort and target trial emulation study

Published:2024-05 Issue: Volume:71 Page:102568
ISSN:2589-5370
Container-title:eClinicalMedicine
language:en
Short-container-title:eClinicalMedicine

Author:

Yang Aimin^ORCID,Shi Mai^ORCID,Wu Hongjiang^ORCID,Lau Eric SH.^ORCID,Cheung Johnny TK.,Zhang Xinge,Fan Baoqi,Chen Tingting,Kong Alice PS.,Luk Andrea OY.,Ma Ronald CW.,Chan Juliana CN.,Chow Elaine^ORCID

Funder

Hospital Authority

Chinese University of Hong Kong

Publisher

Elsevier BV

Reference38 articles.

1. IDF diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045;Sun;Diabetes Res Clin Pract,2021

2. Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options;Jankowski;Circulation,2021

3. Metformin: historical overview;Bailey;Diabetologia,2017

4. 10-year follow-up of intensive glucose control in type 2 diabetes;Holman;N Engl J Med,2008

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucagon-like peptide receptor-1 receptor agonists: The emerging fourth pillar in type 2 diabetes and chronic kidney disease?;Med;2024-08

2. Current type 2 diabetes guidelines: Individualized treatment and how to make the most of metformin;Diabetes, Obesity and Metabolism;2024-07-11

3. Optimizing metformin therapy in practice: Tailoring therapy in specific patient groups to improve tolerability, efficacy and outcomes;Diabetes, Obesity and Metabolism;2024-07-10